Patents for C12P 21 - Preparation of peptides or proteins (112,499)
09/2000
09/14/2000CA2362422A1 Polynucleotides and proteins encoded thereby
09/14/2000CA2361849A1 Promotion or inhibition of angiogenesis and cardiovascularization
09/13/2000EP1035203A1 Genetically engineered cell culture adapted infectious bursal diseases virus (IBDV) mutants
09/13/2000EP1035132A1 Monoclonal antibody inducing apoptosis
09/13/2000EP1034785A2 Hepatitis C virus diagnostics and vaccines
09/13/2000EP1034298A1 Humanization of murine antibody
09/13/2000EP1034297A1 Murd protein and gene of staphylococcus aureus
09/13/2000EP1034296A1 ribH POLYPEPTIDES AND POLYNUCLEOTIDES
09/13/2000EP1034295A1 ribA
09/13/2000EP1034281A1 MAMMARY GLAND TISSUE-SPECIFIC EXPRESSION SYSTEM USING $G(b)-CASEIN PROMOTER SITE OF KOREAN NATIVE GOAT
09/13/2000EP1034276A1 Novel era
09/13/2000EP1034268A1 G-protein coupled receptors and uses therefor
09/13/2000EP1034187A1 $i(IN VITRO) AND $i(IN VIVO) GROWTH-PROMOTING PROTEINS AND PEPTIDES FOR KIDNEY EPITHELIAL CELLS
09/13/2000EP1034185A2 Pharmaceutical compositions containing the long pentraxin ptx3
09/13/2000EP0832207B1 A method for identification of biologically active peptides and nucleic acids
09/13/2000EP0814834B1 Non-toxic immunogens derived from a retroviral regulatory protein, antibodies directed against said immunogens, preparation method therefor, and pharmaceutical compositions containing the same
09/13/2000EP0772624B1 Interleukin-15
09/13/2000EP0571500B1 A high sulfur seed protein gene and method for increasing the sulfur amino acid content of plants
09/13/2000EP0514488B1 Retinoid receptor compositions and methods
09/13/2000EP0183776B2 A process for isolating and activating a substantially insoluble polypeptide using non-ionic detergents.
09/13/2000CN1266103A Method for making biological protein
09/13/2000CN1266100A Chemical synthesis, expression and recombinant protein production for human serum albumin reformed gene
09/13/2000CN1266099A Chemical synthesis, expression and recombinant protein production for human serum albumin reformed gene (I)
09/13/2000CN1266098A Growth mark regulated by growth hormone
09/13/2000CN1266064A Vascalogenesis inhibition factor-endothelial inhibitor and preparation process thereof
09/13/2000CN1056382C Improved HCV diagnostic agents
09/12/2000USRE36866 Anti-aids immunotoxins
09/12/2000US6117991 Plasmid pav2-htsh-beta on deposit as atcc 75505; for recombinant production, diagnosis and therapy of human thyroid cancer; anticarcinogenic agents
09/12/2000US6117983 Methods for purifying authentic IGF from yeast hosts
09/12/2000US6117981 Hybridomas for lung cancer marker and monoclonal antibodies thereof
09/12/2000US6117976 Molecule of polypeptide which binds ligand of calmodulin with affinity depending on calcium ion concentration and polypeptide having binding domain of immunoglobulin; purification; band-shift assays; cell-labeling
09/12/2000US6117839 For increasing bone growth in mammals
09/12/2000US6117665 DNA molecules coding for debranching enzymes derived from plants
09/12/2000US6117662 Respiratory nitrate reductase alpha subunit
09/12/2000US6117654 Nucleotide sequence coding antiinflammatroy proteins; antiarthritic agents; antiinflammatory agents; bronchodilator agents
09/12/2000US6117653 Hepatitis B surface antigen vaccine
09/12/2000US6117652 Production of proteins by cell culture
09/12/2000US6117651 Genetically engineered nucleic acid sequences linked to bacterial promoter and code heterologous polypeptides; for expressing a desired polypeptide in bacterial cells at high levels
09/12/2000US6117639 Screening for enzyme inhibitors against proteases, determining inhibitory activity; novel transcriptional assay using DNA molecules encoding the fusion protein substrates; Hepatitis C Virus NS3 protease or HIV aspartyl protease
09/12/2000US6117426 Human amine transporter polypeptide fragments
09/12/2000US6117421 Method for promoting cell growth and immunosuppression using chaperonin
09/12/2000CA2051375C Process and compositions for the isolation of human relaxin
09/12/2000CA2029408C Antibiotic a/16686 recovery process
09/12/2000CA2021762C Antigens and methods therefor
09/12/2000CA1341097C Factor viii binding domain of von willebrand factor
09/12/2000CA1341095C Cdna coding for the human von willebrand factor, plasmids or phages with such a cdna coding or fragments thereof respectively, micro-organisms and animal or human cell which contain such plasmids or phages, preparation of proteins by the cultivation of the above mentioned hosts, the obtained proteins and pharmaceutical compositions containing a biologically
09/08/2000WO2000052180A1 Methods for generating and screening novel metabolic pathways
09/08/2000WO2000052178A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells
09/08/2000WO2000052155A2 Recombination of insertion modified nucleic acids
09/08/2000WO2000052146A2 Encryption of traits using split gene sequences
09/08/2000WO2000052135A2 Engineering intracellular sialylation pathways
09/08/2000WO2000052041A1 Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with porphyromonas gingivalis
09/08/2000WO2000052028A1 TUMOR NECROSIS FACTOR RECEPTORS 6α and 6$g(b)
09/08/2000WO2000052022A1 Secreted proteins and nucleic acids encoding them
09/08/2000WO2000029583A3 Immunoglobulin superfamily proteins
09/08/2000WO2000026668A3 S100 proteins and autoantibodies as serum markers for cancer
09/08/2000WO2000018238A9 Identification of differentially methylated and mutated nucleic acids
09/08/2000WO2000018212A9 Platelet-derived growth factor c, dna coding therefor, and uses thereof
09/08/2000WO2000012702A3 Human genes differentially expressed in colorectal cancer
09/08/2000WO2000009709A3 Proteases and associated proteins
09/08/2000WO1999049019A8 Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics
09/08/2000WO1999015650A9 Expression of endogenous genes by non-homologous recombination of a vector construct with cellular dna
09/08/2000CA2364997A1 Encryption of traits using split gene sequences
09/08/2000CA2362989A1 Methods for generating and screening novel metabolic pathways
09/08/2000CA2362924A1 Secreted proteins and nucleic acids encoding them
09/08/2000CA2362737A1 Recombination of insertion modified nucleic acids
09/06/2000EP1033406A1 Inducer for production of antigen-specific antibody, expression vector containing gene therefor, and method of inducing production of antigen-specific antibody
09/06/2000EP1033404A1 New gene with down-regulated expression in metastatic human melanoma cells
09/06/2000EP1033403A1 Gene originating in human fetal chondrocytes
09/06/2000EP1033401A2 Expressed sequence tags and encoded human proteins
09/06/2000EP1033135A1 Broadly reactive opsonic antibodies that react with common staphyloccoccal antigens
09/06/2000EP1033134A1 Compositions inhibiting smooth muscle proliferation, method for the diagnosis of arteriosclerosis, and kits therefor
09/06/2000EP1032838A1 125 human secreted proteins
09/06/2000EP1032699A1 High molecular weight gamma-poly(glutamic acid)
09/06/2000EP1032688A1 Single-chain bifunctional glycoprotein hormones
09/06/2000EP1032687A2 Human cdnas encoding polypeptides having kinase functions
09/06/2000EP1032676A2 $i(CHLAMYDIA TRACHOMATIS) GENOMIC SEQUENCE AND POLYPEPTIDES, FRAGMENTS THEREOF AND USES THEREOF, IN PARTICULAR FOR THE DIAGNOSIS, PREVENTION AND TREATMENT OF INFECTION
09/06/2000EP1032674A2 $i(CHLAMYDIA PNEUMONIAE) GENOMIC SEQUENCE AND POLYPEPTIDES, FRAGMENTS THEREOF AND USES THEREOF, IN PARTICULAR FOR THE DIAGNOSIS, PREVENTION AND TREATMENT OF INFECTION
09/06/2000EP1032672A1 Dna19355 polypeptide, a tumor necrosis factor homolog
09/06/2000EP1032670A1 Toso
09/06/2000EP1032668A1 Fibroblast growth factor-19
09/06/2000EP1032667A2 A33-related antigens and their pharmacological uses
09/06/2000EP1032666A1 A NOVEL EGF MOTIF PROTEIN OBTAINED FROM A cDNA LIBRARY OF FETAL LIVER-SPLEEN
09/06/2000EP1032665A1 A human 2-19 protein homologue, z219c
09/06/2000EP1032661A1 Apo-2DcR
09/06/2000EP1032660A1 Method of identifying binding site domains that retain the capacity of binding to an epitop
09/06/2000EP1032597A1 Methods for detection of prion protein as an indication of transmissible spongiform encephalopathies
09/06/2000EP1032594A1 Secreted proteins and polynucleotides encoding them
09/06/2000EP1032593A1 Secreted proteins and polynucleotides encoding them
09/06/2000EP1032589A1 Secreted proteins and polynucleotides encoding them
09/06/2000EP1032582A1 NOVEL recJ
09/06/2000EP1032423A1 Dna encoding mammalian neuropeptide ff (npff) receptors and uses thereof
09/06/2000EP0809806A4 Monoclonal antibodies for human osteogenic cell surface antigens
09/06/2000EP0770089B1 Growth differentiation factor-12
09/06/2000EP0504388B1 Varicella-zoster virus antigen
09/06/2000CN1056189C Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis
09/06/2000CN1056153C Peptide inhibitors of mitogenesis and motorgenesis
09/06/2000CN1056084C Immunotoxins directed against CD33 related surface antigens
09/05/2000US6114598 Generation of xenogeneic antibodies
09/05/2000US6114516 Nucleotide sequences coding for variable regions of the αchains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic muses